ClinicalTrials.govpublic full text
Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
breast cancer, abemeciclib, subtyping -based medicine, post-cdk4/6 inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884383
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.